Dogs, cats may show way to better treatments for human cancers

Cujo romps around the room, seemingly unaware he is missing a front leg, before snuggling in for a caress and reaching up to bestow a canine kiss on his owner Valeria Martinez.

GUELPH, Ont. — Cujo romps around the room, seemingly unaware he is missing a front leg, before snuggling in for a caress and reaching up to bestow a canine kiss on his owner Valeria Martinez.

Being a dog, the nine-year-old Rottweiler is also unaware he is part of a series of cutting-edge studies that researchers at the Ontario Veterinary College in Guelph, Ont., hope might one day help humans with the same kind of cancer that led to his amputation.

“Good boy. Good boy, baby,” Martinez coos as Cujo rolls on his back, then rights himself to continue his three-legged perambulation around the visitors’ room at the OVC’s Mona Campbell Centre for Animal Cancer.

It was here that the canine had his right front leg surgically removed in December after a painful lump in the limb was diagnosed as osteosarcoma, the same type of bone cancer that affected Terry Fox and ended his Marathon of Hope when the malignancy recurred in his lungs. The 22-year-old died in June 1981.

Osteosarcoma in dogs is almost identical to the disease that occurs in teens and young adults, with a similar progression. But canines are 10 times more likely to develop the cancer than humans.

“Just like in people, osteosarcoma in dogs is a highly metastatic disease, meaning it comes back,” says Dr. Paul Woods, a veterinary medical oncologist at the OVC, which is part of the University of Guelph.

In dogs, osteosarcoma occurs most often in large breeds like mastiffs, greyhounds and wolfhounds, although smaller dogs can develop the disease. Standard treatment includes amputating the affected limb, then treating the pet with chemotherapy.

“We do chemotherapy similar to chemotherapy they use in people, and the idea is we’re trying to delay or prevent recurrence of this metastatic disease,” Woods explains.

He concedes, however, that the regimen typically only extends the animal’s life, with most eventually succumbing to the cancer.

But as part of a multicentre trial headed by the U.S. National Institutes of Health, Guelph researchers are testing a drug called rapamycin, which they hope might stop the bone cancer from recurring.

About 160 dogs will be included in the eight- to 12-month study being conducted by the NIH’s Comparative Oncology Trials Consortium at about 20 U.S. sites along with Guelph, with funding from the Morris Animal Foundation, an international non-profit organization that supports veterinary research.

All the animals will get standard care for their cancer, then half will be randomized to receive rapamycin. The drug is used to prevent organ rejection in transplant patients but is being repurposed as a potential anti-cancer medication.

One of those getting the drug is Cujo.

When Martinez first brought her pet to the centre from her home in Barrie, Ont., she was “looking for a miracle” but worried how Cujo would fare with a missing limb.

Three weeks after the operation, Cujo “started to live normally,” she says. While he can no longer manage the daily three-kilometre walks the pair took before he lost his leg, he can run and play in the backyard, “no problem.”

Following the operation, Cujo underwent four rounds of chemotherapy, which Martinez says didn’t seem to bother him beyond being tired the first day of treatment.

The pet is now being monitored to see if his cancer is being held at bay.

“What we’re wondering is will that delay or at best stop the metastatic disease from coming back,” says Woods. “Hopefully it will help dogs, but it may also translate to helping people as well.”

That’s also the goal of another OVC osteosarcoma research project, this one in the lab of viral immunologist Byram Bridle.

With a $450,000 grant from the Terry Fox Foundation, Bridle is laying the groundwork for a three-year study that will test two novel virus-based therapies in dogs with the bone cancer.

One uses a non-disease-causing “oncolytic” virus that has been engineered to target and destroy osteosarcoma cells without harming surrounding healthy cells. The second is a virus-based vaccine that boosts and harnesses the power of the immune system in a bid to wipe out the cancer cells — delivering a one-two punch against the tumour.

“So the concept here is the oncolytic virus will get in and quickly replicate and destroy a lot of the cancer cells, debulking the tumour, and then this overwhelming immune response will come in as a second wave and hopefully kill the remaining cancer cells,” says Bridle, who as a child was inspired by Fox and chose the study of cancer as a career path.

“What kills these animals is when some of the (cancer) cells migrate to other parts of the body,” he says. But because the experimental viruses distribute throughout the body, “we don’t need to know where these tumour cells are — the viruses can seek them out and find them.”

Researchers are in the process of producing clinical batches of the therapies for the trial, which is expected to enrol at least 45 dogs and last about two years once regulatory approval is granted.

“If we can show that the experimental therapy is better … it will allow us to design an optimal therapy to test in human patients,” says Bridle, who is working with collaborators at McMaster University and the Ottawa Hospital Research Institute.

A trial using a similar approach is already underway for cats with the feline version of breast cancer, and researchers hope the results may point to a new way to treat some forms of the disease in humans.

The study is funded by the Canadian Breast Cancer Foundation, the first time the charitable organization has invested in research involving companion animals, says Bridle, who is working on the project with Woods and Brian Lichty of McMaster.

So far, 12 cats have been treated with immunotherapy designed to target feline mammary carcinoma, which typically occurs in older animals that have not been spayed.

Among them is Tabby, a stray adopted 13 years ago by Millie Daley of Hamilton, who also has one of her kittens.

When her local vet discovered Tabby had mammary cancer, Daley turned to the OVC, which agreed to take her pet into the immunotherapy trial.

Over a period of weeks, the cat received one of the vaccines, the tumour was surgically removed and then the second vaccine was administered.

“She had no reaction to either of the vaccines, she just sailed through them,” says Daley, who has brought Tabby in for a followup appointment. “She runs around the house, she has more energy now than she had before all this started.

“It’s a triple win all the way around. She’s getting excellent care and I win because I’m not going bankrupt … and down the road it may even help me or other humans to deal with breast cancer in another way that’s less invasive and may (have) a better result.”

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Erika Fetterly, owner of EFP Studios, recently launched the Let Them Have A Voice campaign. (Contributed photo)
Central Alberta photographer’s campaign aims to give youths a voice

An Innisfail photographer is giving a platform to young central Albertans so… Continue reading

The Red Deer Rebels hosted the Medicine Hat Tigers in the first game of the shortened 2020-21 season on Friday. The two teams faced off again in Medicine Hat Saturday (Photo by Rob Wallator/ Red Deer Rebels)
Red Deer Rebels fall to Medicine Hat Tigers on Saturday

Tigers 7 Rebels 2 The Red Deer Rebels have lost two straight… Continue reading

Alberta has 1,910 active cases of COVID-19 as of Wednesday. Red Deer is reporting five active cases, with 108 recovered. (File photo)
Red Deer reports 25th COVID-19 death

415 new cases identified provincially Saturday

More than 120,000 Albertans have signed up to get the COVID-19 vaccine in the first two days of appointment bookings. (Photo courtesy Alberta Health Services Twitter)
Alberta Health Services apologizes after seniors struggle to book vaccine appointments

The CEO and president of Alberta Health Services is apologizing after seniors… Continue reading

Red Deer’s Kyle Moore, 26, will be a houseguest on Season 9 of Big Brother Canada. (Photo courtesy Big Brother Canada)
Red Deer man will be a houseguest on Big Brother Canada

A Red Deer man will be a houseguest on the upcoming season… Continue reading

Red Deer science-communicating dogs Bunsen and Beaker helped save a missing pet recently. The two dogs have more than 80,000 followers on Twitter. (Contributed photo)
WATCH: Red Deer science dogs help save lost pet

Red Deer science-communicating dogs Bunsen and Beaker helped rescue a missing pet… Continue reading

Alberta Premier Jason Kenney speaks during a news conference in Edmonton on Feb. 24, 2020. It’s budget day in the province, and Kenney’s United Conservative government is promising more help in the fight against COVID, but more red ink on the bottom line. THE CANADIAN PRESS/Jason Franson
Alberta Premier slams vandalism after slur painted on MLA’s office window

EDMONTON — Alberta Premier Jason Kenney is condemning alleged vandalism at the… Continue reading

Canada Pension Plan Investment Board President and Chief Executive Officer Mark Machin waits to appear at the Standing Committee on Finance on Parliament Hill, in Ottawa on Tuesday, November 1, 2016. Executives who engage in so-called "vaccine tourism" show both an ethical disregard for those less fortunate and a surprising lack of business acumen, experts argue. THE CANADIAN PRESS/Adrian Wyld
Vaccine tourism is both unethical and bad for business, experts say

Executives who engage in so-called “vaccine tourism” show both an ethical disregard… Continue reading

Edmonton Oilers' Jesse Puljujarvi (13) and Toronto Maple Leafs' Justin Holl (3) battle in front as goalie Jack Campbell (36) makes the save during second period NHL action in Edmonton on Saturday, February 27, 2021.THE CANADIAN PRESS/Jason Franson
No Matthews, no problem: Minus NHL goal leader, Maple Leafs blank Oilers 4-0

Leafs 4 Oilers 0 EDMONTON — The Maple Leafs knew even with… Continue reading

The Pornhub website is shown on a computer screen in Toronto on Wednesday, Dec. 16, 2020. THE CANADIAN PRESS
Pornhub policies reveal legal gaps and lack of enforcement around exploitive videos

OTTAWA — Serena Fleites was in seventh grade when a sexually explicit… Continue reading

Sean Hoskin stands on a neighbourhood street in Halifax on Thursday, Feb. 25, 2021. Hoskin was diagnosed with COVID-19 almost a year ago with symptoms that still persist. Some provinces have established programs to deal with long-term sufferers but Atlantic Canada, with relatively low numbers of patients, has yet to provide a resource to assist them. THE CANADIAN PRESS/Andrew Vaughan
On East Coast, exhausted COVID-19 ‘long haulers’ hope specialized clinics will emerge

HALIFAX — On evenings when Sean Hoskin collapses into bed, heart pounding… Continue reading

Ottawa Senators goaltender Matt Murray (30) stands in his crease as Calgary Flames left wing Andrew Mangiapane (88), left to right, defenceman Rasmus Andersson (4), Matthew Tkachuk (19), Mikael Backlund (11) and Mark Giordano (5) celebrate a goal during second period NHL action in Ottawa on Saturday, Feb. 27, 2021. THE CANADIAN PRESS/Sean Kilpatrick
Calgary Flames beat Ottawa 6-3 to end Senators’ three-game win streak

Flames 6 Senators 3 OTTAWA — The Calgary Flames used a balanced… Continue reading

Crosses are displayed in memory of the elderly who died from COVID-19 at the Camilla Care Community facility during the COVID-19 pandemic in Mississauga, Ont., on November 19, 2020. The number of people who would have died from a COVID-19 infection is likely to be much higher than recorded because of death certificates don't always list the virus as the cause of a fatality, experts say. THE CANADIAN PRESS/Nathan Denette
Death certificates don’t accurately reflect the toll of the pandemic, experts say

The number of people who would have died from a COVID-19 infection… Continue reading

A health-care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a UHN COVID-19 vaccine clinic in Toronto, Thursday, Jan. 7, 2021. A single dose of Pfizer-BioNTech's COVID-19 vaccine is barely enough to cover the average pinky nail but is made up of more than 280 components and requires at least three manufacturing plants to produce. THE CANADIAN PRESS/Nathan Denette
From science to syringe: COVID-19 vaccines are miracles of science and supply chains

OTTAWA — A single dose of Pfizer-BioNTech’s COVID-19 vaccine is barely enough… Continue reading

Most Read